l-carnitine tmao nature medicine 2013 koeth Gut microbiota derived metabolites in cardiovascular health and disease | Protein & Cell γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Gut microbiota derived metabolite trimethylamine N oxide in major adverse cardiovascular events: Mechanisms, risk assessment, and therapeutic strategies TMAO metaorganismal pathway and chronic inflammatory diseases Gut Microbiota Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
Pay in 4 interest-free payments of $7.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



